Skip to main content

Table 3 Behavioral assessment*

From: Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder

Assessment Baseline Week 4 Week 8
ADHD SC-4 Inattention 18.11 ± 5.37 10.56 ± 5.46a 9.78 ± 6.91a
   median 17 9 10
ADHD SC-4 Hyperactivity 11.33 ± 4.53 7.67 ± 5.96 5.22 ± 3.99a
   median 10 6 4
ADHD SC-4 Oppositional/defiant 10.11 ± 6.79 5.44 ± 3.88b 5.22 ± 3.56b
   median 11 7 5
ADHD SC-4 Conduct disorder 5.22 ± 6.26 0.89 ± 0.93b 1.11 ± 2.26b
   median 4 1 0
CPRS-Oppositional behavior 8.67 ± 4.58 5.38 ± 3.11 4.89 ± 2.93a
   median 7 5.5 6
CPRS- Cognitive problems/inattention 11.56 ± 5.13 7.00 ± 3.89b 8.44 ± 6.48
   median 12 8.5 8
CPRS- Hyperactivity 5.89 ± 3.79 2.63 ± 2.39 3.22 ± 4.49
   median 6 3 2
CPRS- ADHD index 22.67 ± 9.03 13.63 ± 6.37a 15.44 ± 9.49b
   median 22 13 14
Clinical Severity of Illness 4.38 ± 0.74 3.56 ± 0.73 3.33 ± 1.12c
   median 4.5 3 3
  1. * Values are mean ± SD and medians (n = 9). ADHD SC-4, Attention Deficit Hyperactivity Disorder Symptom Checklist 4. CPRS, Conners' Parents Rating Scale a p < 0.01, b p < 0.05 using Wilcoxon signed rank test to compare to baseline; c p = 0.08 using Friedman test to compare to baseline.